Rational Design and Selection of Angiotensinogen-Targeting siRNA Candidates for the Treatment of Hypertension
This framework represents an initial computational step toward developing long-acting RNA interference therapies for hypertension and provides a focused set of AGT-targeting siRNA candidates for future evaluation of off-target effects, delivery efficiency, target accessibility, and gene-silencing activity.